Dhulikhel Hospital, Kathmandu University Hospital, Kavrepalanchok, Nepal.
Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
Clin Infect Dis. 2020 Dec 1;71(Suppl 3):S205-S213. doi: 10.1093/cid/ciaa1319.
Typhoid fever is endemic in the urban Kathmandu Valley of Nepal; however, there have been no population-based studies of typhoid outside of this community in the past 3 decades. Whether typhoid immunization should be prioritized in periurban and rural communities has been unclear.
We performed population-based surveillance for enteric fever in 1 urban catchment (Kathmandu) and 1 periurban and rural catchment (Kavrepalanchok) as part of the Surveillance for Enteric Fever in Asia Project (SEAP). We recruited individuals presenting to outpatient and emergency departments at 2 study hospitals with suspected enteric fever and performed blood cultures. Additionally, we conducted a household survey in each catchment area to characterize care seeking for febrile illness. We evaluated spatial heterogeneity in febrile illness, care seeking, and enteric fever incidence.
Between September 2016 and September 2019, we enrolled 5736 participants with suspected enteric fever at 2 study hospitals. Among these, 304 (5.3%) were culture positive for Salmonella Typhi (249 [81.9%]) or Paratyphi A (55 [18.1%]). Adjusted typhoid incidence in Kathmandu was 484 per 100 000 person-years and in Kavrepalanchok was 615 per 100 000 person-years. While all geographic areas for which estimates could be made had incidence >200 per 100 000 person-years, we observed spatial heterogeneity with up to 10-fold variation in incidence between communities.
In urban, periurban, and rural communities in and around Kathmandu, we measured a high but heterogenous incidence of typhoid. These findings provide some support for the introduction of conjugate vaccines in Nepal, including outside urban areas, alongside other measures to prevent enteric fever.
伤寒在尼泊尔加德满都市区流行;然而,在过去 30 年中,除了这个社区之外,没有关于伤寒的基于人群的研究。在城乡社区是否应优先接种伤寒疫苗一直不清楚。
我们在 1 个城市集水区(加德满都)和 1 个城郊和农村集水区(卡瓦雷帕兰乔克)进行了肠热病的基于人群的监测,作为亚洲肠热病监测项目(SEAP)的一部分。我们招募了在 2 家研究医院的门诊和急诊部门就诊的疑似肠热病患者,并进行了血培养。此外,我们在每个集水区进行了家庭调查,以描述发热性疾病的就医情况。我们评估了发热性疾病、就医和伤寒发病率的空间异质性。
在 2016 年 9 月至 2019 年 9 月期间,我们在 2 家研究医院招募了 5736 名疑似肠热病患者。其中,304 人(5.3%)的血培养阳性为伤寒沙门氏菌(249 人[81.9%])或甲型副伤寒沙门氏菌(55 人[18.1%])。加德满都的调整后伤寒发病率为每 100000 人年 484 例,卡瓦雷帕兰乔克的发病率为每 100000 人年 615 例。虽然所有可以进行估计的地理区域的发病率均超过 200 例/100000 人年,但我们观察到发病率存在空间异质性,社区之间的发病率差异高达 10 倍。
在加德满都及其周围的城乡社区,我们测量到的伤寒发病率很高,但存在异质性。这些发现为在尼泊尔(包括城市地区以外)引入结合疫苗提供了一些支持,同时还需要采取其他措施来预防肠热病。